Therapeutic use of a Fraximus augustifolia extract
US11590189B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2017 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Feb 27, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2200/328
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to extracts from Fraxinus angustifolia samara, processes for providing such extracts, and methods and uses of the extracts obtained. In particular, the present invention relates to the use of such extracts in reversing obesity-related and/or metabolic syndrome-related gut microbiota dysbiosis treatment, treating or preventing hepatic steatosis, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), and modulating and/or adjusting gut microbiota.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.